INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 424m ago
HOUSE PTR23m ago
SEC 13F23m ago
ROBINHOOD CHAIN23m ago
Public company

SNGXSOLIGENIX, INC.

CIK 0000812796

EDGAR filingsOpen in network
Disclosed transactions12
Buys / sells0 / 0
Max Insider Score9
Connections3with evidence

SNGX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
GL
Guarino Jonathan L.CFO
SNGXSOLIGENIX, INC.
Disposition to issuer
D—
41 sh
Oct 12, 2026Oct 13, 2026
traded Oct 12, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Guarino Jonathan L.CFO · Oct 13, 2026
  • ← Insider ofevidence
    Parks Diane L.Director · Sep 18, 2026
9
GL
Guarino Jonathan L.CFO
SNGXSOLIGENIX, INC.
Disposition to issuer
D
—
208 sh
Oct 12, 2026
Oct 13, 2026
traded Oct 12, 2026
+1d
SEC FORM 4

Evidence

9
GL
Guarino Jonathan L.CFO
SNGXSOLIGENIX, INC.
Disposition to issuer
D—
333 sh
Oct 12, 2026Oct 13, 2026
traded Oct 12, 2026
+1dSEC FORM 4

Evidence

9
PL
Parks Diane L.Director
SNGXSOLIGENIX, INC.
Disposition to issuer
D—
6 sh
Oct 12, 2026Oct 13, 2026
traded Oct 12, 2026
+1dSEC FORM 4

Evidence

9
PL
Parks Diane L.Director
SNGXSOLIGENIX, INC.
Disposition to issuer
D—
128 sh
Oct 12, 2026Oct 13, 2026
traded Oct 12, 2026
+1dSEC FORM 4

Evidence

9
PL
Parks Diane L.Director
SNGXSOLIGENIX, INC.
Disposition to issuer
D—
56 sh
Oct 12, 2026Oct 13, 2026
traded Oct 12, 2026
+1dSEC FORM 4

Evidence

9
PL
Parks Diane L.Director
SNGXSOLIGENIX, INC.
Disposition to issuer
D—
63 sh
Oct 12, 2026Oct 13, 2026
traded Oct 12, 2026
+1dSEC FORM 4

Evidence

9
PL
Parks Diane L.Director
SNGXSOLIGENIX, INC.
Disposition to issuer
D—
121 sh
Oct 12, 2026Oct 13, 2026
traded Oct 12, 2026
+1dSEC FORM 4

Evidence

9
PL
Parks Diane L.Director
SNGXSOLIGENIX, INC.
Disposition to issuer
D—
192 sh
Oct 12, 2026Oct 13, 2026
traded Oct 12, 2026
+1dSEC FORM 4

Evidence

9
GL
Guarino Jonathan L.CFO
SNGXSOLIGENIX, INC.
Disposition to issuer
D—
166 sh
Oct 12, 2026Oct 13, 2026
traded Oct 12, 2026
+1dSEC FORM 4

Evidence

9
GL
Guarino Jonathan L.CFO
SNGXSOLIGENIX, INC.
Disposition to issuer
D—
166 sh
Oct 12, 2026Oct 13, 2026
traded Oct 12, 2026
+1dSEC FORM 4

Evidence

9
PL
Parks Diane L.Director
SNGXSOLIGENIX, INC.
Grant or award
A—
78.9K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC FORM 4

Evidence